Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius

International Journal of Obesity

Volumn 22, Issue 2, 1998, Pages 171-177

  Zimmet, P Z ^a   Collins, V R ^a   De Courten, M P ^a   Hodge, A M ^a   Collier, G R ^b   Dowse, G K ^c   Alberti, K G M M ^d   Tuomilehto, J ^e   Hemraj, F ^f   Gareeboo, H ^f   Chitson, P ^f   Fareed, D ^g  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c Disease Control Service   (Australia)

^d Department of Medicine ^*  (United Kingdom)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f Ministry of Health   (Mauritius)

^g WHO Office   (Mauritius)

Author keywords

Insulin sensitivity; Leptin; Obesity; Population based study

Indexed keywords

INSULIN; LEPTIN;

ADULT; AGED; ARTICLE; BODY MASS; ETHNOLOGY; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MAURITIUS; MULTIPLE REGRESSION; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL;

MAURITIUS;

EID: 3042715083     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800559     Document Type: Article

References (47)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J. Positional cloning of the mouse obese gene and its human homolgue. Nature 1994; 372: 425-432.
2. Tartaglia L, Dembski M, Weng X, Deng N, Culepper J, Devos R, Richards G, Campfield L, Clark F, Deeds J, Muir C, Sanker S, Moriarty A, Moore K, Smutko J, Mays G, Woolf E, Monroe C, Tepper R. Identification and expression cloning of a leptin receptor. OB-R. Cell 1995; 85: 1265-1271.
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rahinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
4. Pelleymounter M, Cullen M, Baker M, Hecht R, Winters D, Boone T, Collins F. Fffeets of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 5410-543.
5. Cusin I, Rohner-Jeanrenaud F, Stricker-Krongrad A, Jeanrenaud B. The weight-reducing effect of an intracerebro-ventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes 1996; 45: 1446-1450.
6. Frederich RC, Hamann A, Anderson S, Löllman B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nature Medicine 1995; 1: 1311-1314.
7. Collier G, Walder K, Lewandowski P, Sanigorski A, Lee S, Zimmet P. Development of obesity and hyperleptinemia in Psammomys obesus. Diabetologia 1996; 39 (Suppl 1): A146.
8. Maffei M, Halaas J, Ravussin E, Prateley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995; 1: 1155-1161.
9. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
10. Zimmet P, Hodge A, Nicolson M, Staten M, do Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 1996; 313: 965-969.
11. Kolaezynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF. Acute and chronic effects of insulin on leptin production in humans. Studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
12. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996; 45: 1435-1438.
13. Gabriel M, Jinagouda S, Boyadjian R, Kades W, Ayad M, Saad M. Is leptin the link between obesity and insulin resistance? Diabetes 1996; 45 (Suppl 2): 51A.
14. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45: 695-698.
15. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45: 988-991.
16. Kolaczynski JW, Caro JF. Molecular mechanism of insulin resistance in human obesity. Current Opinion in Endocrinology and Diabetes 1996; 3: 36-43.
17. Dowse G, Ciareeboo H, Zimmet P, Alberti K, Tuomilehto J, Farced D, Brissonnette L, Finch C. High prevalence of NIDDM and impaired glucose tolerance in Indian. Creole and Chinese Mauritians. Diabetes 1990; 39: 390-396.
18. Dowse G, Zimmet P, Gareeboo H, Alberti K, Tuomilehto J, Finch C, Chitson P, Tulsidas H. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole and Chinese Mauritians. Diab Care 1991; 14: 271-282.
19. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. WHO, Geneva: 1985.
20. Soeldner J, Slone D. Critical variables in radioimmunoassay of serum insulin using the double antibody technique. Diabetes 1965; 14: 771-779.
21. Dowse G, Zimmet P, Alberti K, Brigham L, Carlin J, Tuomilehto J, Knight L, Gareeboo H. Serum insulin distributions and reproducibility of the relationship between 2-hour insulin and plasma glucose levels in Asian Indian, Creole and Chinese Mauritians. Metabolism 1993; 42: 1232-1241.
22. Laakso M. How good a marker is insulin level for insulin resistance? Amer Epidemiol 1993; 137: 959-965.
23. SPSS PC + 4.0 for the IBM PC/XT/AT and PS/2 [program]. SPSS Inc., Chicago: 1990.
24. Rudenski A, Matthews D, Levy J, Turner R. Understanding 'Insulin Resistance': Both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 1991; 40: 908-917.
25. Jockenhövel F, Blum W, Vogel E, Englaro P, Müller-Wieland D, Dankwart R, Rascher W, Krone W. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. Clin Endocrinol and Metab 1997; 82: 2510-2513.
26. Masuzaki H, Hosoda K, Ogawa Y, Miyawaki T, Hiraoka J, Hanaoka I, Yasuno A, Natsui K, Sugawara A, Arii S, Yoshima Y, Nishi S, Yamori Y, Nakao K. Glucocorticoid and gender regulate plasma leptin levels in humans. Diabetologia 1997; 40(Suppl. 1): A175.
27. Havel PJ, Kasim-Karak S, Dubuc GR, Muhler W, Phinney SD. Gender differences in plasma leptin concentrations. Nature Medicine 2: 949-950 (Letter).
28. Kennedy A, Gettys T, Watson P, Wallace P, Ganaway E, Pan Q, Garvey W. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82: 1293-1300.
29. Rosenbaum M, Nocolson M, Hirsch J, Heymsfield S, Gallagher D, Chu F, Leibel R. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81: 3424-3427.
30. Nyholm B, Fisker S, Lund S, Møller N, Schmitz O. Increased circulating leptin concentrations in insulin-resistant first-degree relatives of patients with non-insulin-dependent diabetes mellitus: relationship to body composition and insulin sensitivity but not to family history of non-insulin-dependent diabetes mellitus. Eur J Endocrinol 1997; 136: 173-179.
31. Dowse G, Qin H, Collins V, Zimmet P, Alberti K, Gareeboo H. Determinants of estimated insulin resistance and B-cell function in Indian, Creole and Chinese Mauritians. Diab Res Clin Prac 1990; 10: 265-279.
32. Multi-Centre S. UK prospective diabetes study. v. Characteristics of newly presenting type 2 diabetic patients: estimated insulin sensitivity and islet B-cell function. Diab Med 1988; 5: 444-448.
33. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and B-cell function from tasting plasma glucose and insulin concentrations in man. Diahetologia 1985; 28: 412-419.
34. Haffner S, Gonzalez C, Miettinen H, Kennedy E, Stern M. A prospective analysis of the HOMA model: The Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138-1141.
35. Haffner S, Miettinen H, Stern M. The homeostatis model in the San Antonio Heart Study. Diabetes Care 1997; 20: 1087-1092.
36. Havel P, Kasim-Karakas S, Mueller W, Johnson P, Gingerich R, Stern J. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 1996; 81: 4406-4413.
37. Dua A, Hennes M, Hoffman R, Maas D, Krakower G, Sonnenberg G, Kissebah A. Leptin: A significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 1996; 45: 1635-1637.
38. Larsson H, Elmståhl S, Ahrén B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996; 45: 1580-1584.
39. Kohrt W, Landt M, Birge Jr S. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. J Clin Endocrinol Metab 1996; 81: 3980-3985.
40. Turpeinen A, Haffner S, Louheranta A, Niskanen L, Miettinen H, Uusitupa M. Serum leptin in subjects with impaired glucose tolerance in relation to insulin sensitivity and first-phase insulin response. Int J Obes 1997; 21: 284-287.
41. Stolk R, Janssen J, Pols H, Englaro P, Blum W, Attanasio A, Grobbee D, Lamberts S. Insulin and leptin are related independently from body mass index. Diabetologia 1997; 40: A262.
42. Haffner S, Miettinen H, Mykkänen L, Karhapää P, Rainwater D, Laakso M. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes 1997; 21: 393-399.
43. Malmström R, Taskinen M-R, Karonen S-L, Yki-Jävinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
44. Utriainen T, Malmström R, Mäkimattila S, Yki-Järvinen H. Supraphysiological hyperinsuliemia increases plasma leptin concentrations after 4 h in normal subjects. Diabetes 1996; 45: 1364-1366.
45. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
46. Walder K, Filippis A, Clark S, Zimmet P, Collier G. Leptin inhibits insulin binding in isolated rat adipocytes. Diabetologia 1997; 40:A 176.
47. Norman R, Leibel R, Chung W, Power-Kehoe L, Chua SJ, Knowler W, Thompson D, Bogardus C, Ravussin E. Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Prima Indians. Diabetes 1996; 45: 1229-1232.